In the News

1855 News Items found
microscope image of the SARS-CoV-2 virus
MSK researchers are helping to map the landscape of viruses that infect us all, and to analyze the impact they have on human health and disease.
Monique James
Meet Dr. Monique James, who is part of MSK’s Department of Psychiatry and Behavioral Sciences. Her journey with MSK started 18 years ago before she even started medical school. 
MSK gynecologic surgeon Dr. Mario Leitao and Dr. Anh Le.
Patient Story
Read about a medical student treated at MSK for aggressive cervical cancer who later returned to train alongside MSK surgeons.
Dr. Helena Yu
Q&A
Learn about lung cancer in women, the links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.
A researcher working in an MSK lab
MSK research provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis of brain diseases by revealing how different parts of the brain are metabolizing nutrients; describes a new method to aid the study of rare but influential cell populations; and identifies a potential treatment for malignant peripheral nerve sheath tumors.
MSK patient Aaron von Freter
MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of their treatment offers them a better chance of being cured.
Black male prostate cancer patient smiling.
Ask the Expert
Learn why Black men should be especially mindful of prostate cancer risk.
MSK surgeon-scientist Vinod Balachandran.
Article
Read about new findings on how tertiary lymphoid structures form to fight foreign threats such as cancer.
Adrienne Boire
Neuro-oncologist Dr. Adrienne Boire discusses her path to becoming a cancer researcher, and on the parallel between science and another passion — knitting.
Dr. Debyani Chakravarty
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.